Premium
Celcuity Inc (CELC)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3... Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -46 | -34.518985442 | 133.26 | 138.26 | 87.26 | 2118421 | 108.70485875 | CS |
| 4 | -53.29 | -37.9153326218 | 140.55 | 142.815 | 87.26 | 1321346 | 122.78534567 | CS |
| 12 | -31.1 | -26.2757688408 | 118.36 | 151.02 | 87.26 | 1016471 | 122.06945972 | CS |
| 26 | -11.07 | -11.2580087461 | 98.33 | 151.02 | 87.26 | 852540 | 115.33144252 | CS |
| 52 | 75.61 | 649.012875536 | 11.65 | 151.02 | 11.085 | 992874 | 79.03989348 | CS |
| 156 | 76.21 | 689.683257919 | 11.05 | 151.02 | 7.575 | 475944 | 59.33592833 | CS |
| 260 | 62.32 | 249.879711307 | 24.94 | 151.02 | 4.81 | 309743 | 55.61910565 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
